Megan D. Hoeksema

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

Xiangming Ji, Jun Qian, S.M. Jamshedur Rahman et al. · Oncogene · 2018 · 370 citations · Full text

Medicine, Cancer Biology, Oncology +12

SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival

Mohamed Hassanein, Megan D. Hoeksema, Masakazu Shiota et al. · Clinical Cancer Research · 2012 · 352 citations

Life Sciences, Molecular Biology, Oncology +14

Targeting <scp>SLC1a5</scp>‐mediated glutamine dependence in non‐small cell lung cancer

Mohamed Hassanein, Jun Qian, Megan D. Hoeksema et al. · International Journal of Cancer · 2015 · 164 citations · Full text

Medicine, Oncology, Pharmacology +13

The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers

Jun Qian, Mohamed Hassanein, Megan D. Hoeksema et al. · Proceedings of the National Academy of Sciences · 2015 · 101 citations · Full text

Medicine, Molecular Biology, Oncology +17

Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer

Akshata R. Udyavar, Megan D. Hoeksema, Jonathan E. Clark et al. · BMC Systems Biology · 2013 · 84 citations · Full text

Medicine, Molecular Biology, Oncology +17